{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:37:10Z","timestamp":1792816630133,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2019YFA0111000"],"award-info":[{"award-number":["2019YFA0111000"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtct.2026.09.036","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:31:44Z","timestamp":1790699504000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lineage Plasticity\u2013Mediated Resistance to CD7-Directed CAR-T Therapy in Relapsed\/Refractory T-ALL\/LBL"],"prefix":"10.1016","author":[{"given":"Jiahua","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhen","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4151-1259","authenticated-orcid":false,"given":"Fang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongmei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6618-6993","authenticated-orcid":false,"given":"Jingwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9684-4563","authenticated-orcid":false,"given":"Baoxia","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4995-0838","authenticated-orcid":false,"given":"Haopeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0637-5324","authenticated-orcid":false,"given":"Xianmin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.jtct.2026.09.036_bib0001","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1182\/blood-2009-08-231217","article-title":"T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII\/ECOG 2993)","volume":"114","author":"Marks","year":"2009","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jtct.2026.09.036_bib0002","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2014-10-551895","article-title":"How I treat T-cell acute lymphoblastic leukemia in adults?","volume":"126","author":"Litzow","year":"2015","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2026.09.036_bib0003","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1182\/blood-2002-01-0110","article-title":"Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia","volume":"99","author":"Hoelzer","year":"2002","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2026.09.036_bib0004","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3324\/haematol.10882","article-title":"Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial","volume":"92","author":"Hunault","year":"2007","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.jtct.2026.09.036_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2019.101097","article-title":"Chimeric antigen receptor T cells (CAR-T) for the treatment of T-cell malignancies","volume":"32","author":"Cooper","year":"2019","journal-title":"Best Pract Res Clin Haematol"},{"issue":"4","key":"10.1016\/j.jtct.2026.09.036_bib0006","first-page":"321","article-title":"Naturally selected CD7 CAR-T therapy without genetic manipulations for T-ALL\/LBL: first-in-human phase 1 clinical trial","volume":"140","author":"Lu","year":"2022","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2026.09.036_bib0007","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1002\/ajh.27094","article-title":"Analysis of 60 patients with relapsed or refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma treated with CD7-targeted chimeric antigen receptor-T cell therapy","volume":"98","author":"Zhang","year":"2023","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.jtct.2026.09.036_bib0008","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.ymthe.2024.09.006","article-title":"Autologous CD7 CAR-T cells generated without T cell pre-selection in pediatric patients with relapsed\/refractory T-ALL: a phase I trial","volume":"33","author":"Zhao","year":"2025","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.jtct.2026.09.036_bib0009","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-023-01427-3","article-title":"Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia","volume":"16","author":"Tan","year":"2023","journal-title":"J Hematol Oncol"},{"issue":"8","key":"10.1016\/j.jtct.2026.09.036_bib0010","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1158\/1078-0432.CCR-22-2924","article-title":"Single-cell transcriptomics reveals immune reconstitution in patients with R\/R T-ALL\/LBL treated with donor-derived CD7 CAR-T therapy","volume":"29","author":"Chen","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.jtct.2026.09.036_bib0011","doi-asserted-by":"crossref","DOI":"10.1097\/BS9.0000000000000220","article-title":"A shadow in the treatment of acute leukemia: lineage switch","volume":"7","author":"Zhou","year":"2025","journal-title":"Blood Sci"},{"issue":"14","key":"10.1016\/j.jtct.2026.09.036_bib0012","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1182\/blood.2021013442","article-title":"Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemia","volume":"139","author":"Chen","year":"2022","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.jtct.2026.09.036_bib0013","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1182\/blood.2019004547","article-title":"Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL","volume":"137","author":"Anand","year":"2021","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jtct.2026.09.036_bib0014","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1182\/blood.2025028387","article-title":"Phase 1\/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed\/refractory T-cell malignancies","volume":"146","author":"Ghobadi","year":"2025","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2026.09.036_bib0016","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2026.09.036_bib0017","first-page":"417","article-title":"Chinese guideline for diagnosis and treatment of adult acute lymphoblastic leukemia (2024)","volume":"45","year":"2024","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"27","key":"10.1016\/j.jtct.2026.09.036_bib0018","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.jtct.2026.09.036_bib0019","first-page":"2275","article-title":"The International consensus classification of acute leukemias of ambiguous lineage","volume":"141","author":"Weinberg","year":"2023","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2026.09.036_bib0020","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.immuni.2020.07.011","article-title":"Chimeric antigen receptor designed to prevent ubiquitination and downregulation showed durable antitumor efficacy","volume":"53","author":"Li","year":"2020","journal-title":"Immunity"},{"issue":"30","key":"10.1016\/j.jtct.2026.09.036_bib0021","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1200\/JCO.21.00389","article-title":"Donor-derived CD7 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia: first-in-human, phase I trial","volume":"39","author":"Pan","year":"2021","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.jtct.2026.09.036_bib0022","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood.2025029299","article-title":"Donor-derived CD7 CAR T cells for pediatric and adult relapsed\/refractory T-ALL\/LBL: a phase 2 trial","volume":"146","author":"Pan","year":"2025","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtct.2026.09.036_bib0023","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1111\/bjh.19445","volume":"204","author":"Cao","year":"2024","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jtct.2026.09.036_bib0024","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jtct.2022.11.013","article-title":"Donor CD7 chimeric antigen receptor T cell bridging to allogeneic hematopoietic stem cell transplantation for T cell hematologic malignancy","volume":"29","author":"Li","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.jtct.2026.09.036_bib0025","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1182\/blood.V74.6.2088.2088","article-title":"Molecular heterogeneity in acute leukemia lineage switch","volume":"74","author":"Gagnon","year":"1989","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2026.09.036_bib0026","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3324\/haematol.2023.283705","article-title":"Myeloid lineage switch in KMT2A-rearranged acute lymphoblastic leukemia treated with lymphoid lineagedirected therapies","volume":"109","author":"Bataller","year":"2024","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.jtct.2026.09.036_bib0027","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1182\/blood.2024026655","article-title":"Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia","volume":"146","author":"Silbert","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.09.036_bib0028","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/406796","article-title":"Lineage switching in acute leukemias: a consequence of stem cell plasticity?","volume":"2012","author":"Dorantes-Acosta","year":"2012","journal-title":"Bone Marrow Res"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726007669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726007669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:48:36Z","timestamp":1792813716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726007669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":27,"alternative-id":["S2666636726007669"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.09.036","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lineage Plasticity\u2013Mediated Resistance to CD7-Directed CAR-T Therapy in Relapsed\/Refractory T-ALL\/LBL","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.09.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}